NASDAQ: DRTS
Alpha Tau Medical Ltd.
Healthcare · Biotechnology
Market Cap
$844.55M
52w High
$11.62
52w Low
$2.81
P/E
-14.75
Volume
1.37M
Outstanding Shares
90.33M
Price vs Fundamentals
Why The Stock Is Moving
What changed
The stock rose 232.74% over the last year.
What the market seems to be pricing
The stock has moved higher with no clear directional signal from operating metrics. The operating data does not yet tell a clear story — the move may reflect sentiment, sector rotation, or macro factors rather than company-specific earnings power.
What would invalidate this read
A decisive shift in revenue or cash flow over the next period would be the clearest signal to resolve the ambiguity.
Company profile
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States.
Valuation
Stock splits
No stock splits recorded for this ticker.
Profitability & growth
Analyst consensus
5
Buy
1
Hold
0
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Aug 10, 2026
Q3 FY26 · EPS est -$0.14 · Revenue est $144.5K
View